Tagged neurodegeneration

Press Release

Elixiron Immunotherapeutics Receives Grant From the Alzheimer's Association to Trial Microglia-Targeting Immunotherapy

 Read More
Press Release

Neurocentria Obtains FDA Approval to Conduct Pivotal Phase IIb/III Clinical Trial for Testing Safety and Efficacy of Drug Candidate NRCT-101SR in Adults With ADHD

Novel NRCT-101SR shown in previous human studies to be effective and well-tolerated with no side effects

 Read More
Enterin Announces That the Enteric Nervous System Directly Impacts Neuropsychiatric Symptoms
Press Release

Enterin Announces That the Enteric Nervous System Directly Impacts Neuropsychiatric Symptoms

 Read More
Enterin Announces Appointment of Dr. Roger Mills to Its Board of Directors
Press Release

Enterin Announces Appointment of Dr. Roger Mills to Its Board of Directors

 Read More
Enterin Announces Appointment of Hilde Williams as Senior Regulatory Advisor
Press Release

Enterin Announces Appointment of Hilde Williams as Senior Regulatory Advisor

 Read More
Press Release

Bioinduction Announces the World's First Successful Implantations of 'PICOSTIM', a Novel, Less Invasive, Self-Contained Cranialized 'Brain Pacemaker' for Parkinson's Disease

Small, smart, single-stage skull implanted DBS system can be implanted in under half the time of conventional implantations

 Read More
Enterin to Present at JMP Securities Life Sciences Conference
Press Release

Enterin to Present at JMP Securities Life Sciences Conference

 Read More
Press Release

Elixiron Immunotherapeutics Awarded Alzheimer's Association Grant to Target Microglia in Alzheimer's Disease

 Read More
NAD Treatment Center Contributes to Potential a Treatment for Alzheimer's by Participating in Young Blood Institute Study
Press Release

NAD Treatment Center Contributes to Potential a Treatment for Alzheimer's by Participating in Young Blood Institute Study

 Read More
Early Alzheimer's Disease: Finding the Right Patients for Clinical Trials and Beyond, New Webinar Hosted by Xtalks
Press Release

Early Alzheimer's Disease: Finding the Right Patients for Clinical Trials and Beyond, New Webinar Hosted by Xtalks

Industry experts will tackle the challenge of recruiting patients with early stage Alzheimer's disease into clinical trials to expedite treatment development

 Read More
Longevity Biotech Awarded Grant From National Multiple Sclerosis Society to Evaluate LBT-3627 as a Novel Drug Candidate for Multiple Sclerosis
Press Release

Longevity Biotech Awarded Grant From National Multiple Sclerosis Society to Evaluate LBT-3627 as a Novel Drug Candidate for Multiple Sclerosis

Launches preclinical development effort of LBT-3627 as a neuroprotective/repair treatment for Multiple Sclerosis

Read More
Breakthrough Regenerative Therapeutics Company Establishes Scientific Advisory Board
Press Release

Breakthrough Regenerative Therapeutics Company Establishes Scientific Advisory Board

 Read More
Longevity Biotech and University of Nebraska Medical Center Awarded Continuing Grant from the Michael J. Fox Foundation for Parkinson's Research
Press Release

Longevity Biotech and University of Nebraska Medical Center Awarded Continuing Grant from the Michael J. Fox Foundation for Parkinson's Research

Furthers development of LBT-3627 focusing on immunomodulatory therapeutic strategy to treat Parkinson's disease

 Read More
QR Pharma Announces New Scientific Advisory Board
Press Release

QR Pharma Announces New Scientific Advisory Board

Four Neurology Experts Join Advisory Board Following Recent Breakthrough Discoveries Regarding Posiphen Mechanism of Action

 Read More